12/11
12:54 pm
clrb
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
Low
Report
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
12/11
12:47 pm
clrb
Rating for CLRB
Low
Report
Rating for CLRB
12/11
12:47 pm
clrb
Rating for CLRB
Low
Report
Rating for CLRB
12/11
08:47 am
clrb
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
High
Report
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
12/11
08:47 am
clrb
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
High
Report
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
11/19
08:22 am
clrb
Rating for CLRB
Medium
Report
Rating for CLRB
11/19
08:22 am
clrb
Rating for CLRB
Medium
Report
Rating for CLRB
10/11
03:01 pm
clrb
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $14.00 price target on the stock.
Low
Report
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $14.00 price target on the stock.
10/11
01:49 pm
clrb
Rating for CLRB
Low
Report
Rating for CLRB
10/11
01:49 pm
clrb
Rating for CLRB
Low
Report
Rating for CLRB